Navonil DS@Navonilde

(Pronouns He/Him). DAD/Husband/Scientist @ProstateCancer @CancerGenomics @Biomarker_Research @Mountain_Lover @DNA repair @Signature 'tweet are mine'

 Seattle, WA
Joined May 2009
89 Photos and videos
Excited to release my lab's first preprint! A foundational model for clone & epistasis-aware biomarkers. This approach addresses key challenges in understanding genetic interactions & clonal dynamics. Looking forward to feedback & new collaborations! biorxiv.org/content/10.1101/…

CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and...

Current DNA damage repair (DDR) biomarkers employ binary classifications that fail to capture the molecular complexity of tumors with concurrent repair deficiencies. We used genomics analysis to...

biorxiv.org
1
5
134
Delighted that he is joining precision/rare/phase 1
OncoDaily
@oncodaily
Sep 3
Replying to @waraonc23 @MedicalCollege @MCWCancerC2u8v @Dr_R_Kurzrock @huizichen
Happy to Join MCW Cancer Center as Assistant Professor and Medical Oncologist - Yu Fujiwara @waraonc23jp oncodaily.com/career/yu-fuji…
2
18
3,092
Navonil DS retweeted
Dr. Bishoy M. Faltas@FaltasLab
Jul 27
I’m excited to launch Science in GU Oncology, a new monthly newsletter in partnership with @urotoday Each issue will cover the latest scientific advances in GU cancers and what they mean for patient care. bit.ly/4bMIfPn
3
25
77
4,972
One diagnosis sparked a movement. 💙 After being diagnosed with advanced prostate cancer, Michael Milken founded the Prostate Cancer Foundation. His mission: accelerate research and improve outcomes for patients everywhere. More than 30 years later, that mission remains true.
2
6
569
Navonil DS retweeted
Dr. Thomas Ichim
@exosome
Jul 18
Finally !! a CAR-T that works on solid tumors. Nature paper… 32 out of 36 patients had regression of advanced #cancer. Target rglypican and tgf beta. @IntegrativeCCA $IBRX #anktiva will enhance nature.com/articles/s41586-0…

GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma

Nature - Chimeric antigen receptor (CAR) T cells for antitumour therapy ‘armoured’ with a dominant-negative TGFβ receptor II show enhanced efficacy and tolerable safety in patients...

nature.com
14
84
469
74,707
The Center for Precision Oncology and Rare Cancers/Precision Medicine and Rare Cancer Clinic at MCW could not function without our pharmacists pubmed.ncbi.nlm.nih.gov/4245…
4
18
1,503
Navonil DS retweeted
Cancer Discovery@CD_AACR
Jul 14
Now online: Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T Cells in KRAS -Mutant Cholangiocarcinoma doi.org/10.1158/2159-8290.CD…
1
8
14
2,436
Navonil DS retweeted
Cancer Discovery@CD_AACR
Jul 3
Now online: Germline CDK12 variants in aggressive prostate cancer doi.org/10.1158/2159-8290.CD…
6
9
8,811
Navonil DS retweeted
Vivek Subbiah, MD
@VivekSubbiah
Jul 1
FDA approves Orca Bio’s T cell therapy for blood cancer patients statnews.com/2026/07/01/fda-… via @statnews

FDA approves Orca Bio’s T cell therapy for blood cancer patients

The FDA approved a T-cell therapy from Orca Bio that reduces the risk of a debilitating immune reaction in patients with blood cancers undergoing stem cell transplants.

statnews.com
3
9
1,188
Hope changes everything. At its heart, the Michels’ $27 million gift to MCW’s Center for Cancer Discovery is about the families facing a cancer diagnosis today—and those who will face one tomorrow. By investing in groundbreaking research, Tim and Barbara Michels are helping bring new hope, new possibilities, and new pathways to better outcomes for patients everywhere.
1
5
657
Can't agree more.
Prostate Cancer Foundation@PCFnews
May 12
PCF Young Investigator Awards recognize early career scientists poised to lead the future of prostate cancer research. Andrea Miyahira, Ph.D., PCF VP of Global Research & Innovation, shares how these awards help accelerate promising research careers.
1
97
Navonil DS retweeted
nature
@Nature
May 7
Obituary: J Craig Venter (1946-2026) maverick biotechnologist who sequenced the human genome go.nature.com/4dussWD

J. Craig Venter obituary: maverick biotechnologist who sequenced the human genome

Nature - The entrepreneur was also a pioneer of synthetic biology.

nature.com
9
164
499
33,505
Navonil DS retweeted
Charles Swanton@CharlesSwanton
Apr 29
Online here: nature.com/articles/s41586-0… Open access here: rdcu.be/ff6YJ Key supporters of this work are @CR_UK , @CRUKLungCentre , @UCLHresearch alongside many others

Evolutionary characterization of lung cancer metastasis

Nature - DNA-sequencing data from primary tumours and paired metastases from participants in the TRACERx lung study and PEACE autopsy programme are used to analyse the metastatic diversity of...

nature.com
6
68
192
24,490
As we close out #WomensHistoryMonth, we honor the women of PCF whose leadership is helping shape the future of prostate cancer. Their voices, and women’s voices everywhere, spark conversations that lead to early detection and save lives. 💙
1
2
16
569
If you or a loved one has prostate cancer, germline genetic and somatic testing can open doors—to better treatment options, clinical trials, and a clearer picture of your family's cancer risk. Medical oncologist Dr. @EHeath4100 walks you through: bit.ly/47wv4Qt #MedEd
7
8
667
FUO 2026 applications are open! Senior urology residents (PGY3 in Aug 2026) are invited to join the inaugural SUO Future Urologic Oncologists program in Indianapolis (July 24–26) for mentorship, education, and networking with leaders in urologic oncology. Apply by April 20!
1
12
16
4,394
Prostate Cancer Working Group 4: What Does Its Work Mean for the Busy Clinician? dailynews.ascopubs.org/do/pr… Stay tuned this Thursday at #GU26 and @JCO_ASCO! @DukeGUCancer @DukeCancer @ThePCCTC

Prostate Cancer Working Group 4: What Does Its Work Mean for the Busy Clinician?

At the 2026 ASCO Genitourinary Cancers Symposium, the international, multidisciplinary Prostate Cancer Working Group 4 will present its multiyear work to address unmet needs in the field of clinical...

dailynews.ascopubs.org
7
24
3,083
Join us in ending the stigma of getting tested for prostate cancer – early detection can save lives. Get a simple PSA blood test. Check the Box!
MM+M@MMMnews
Feb 23
Basketball Hall of Fame checks in to Prostate Cancer Foundation effort to save lives mmm-online.com/news/basketba… @PCFnews
2
6
699
Thrilled to share the latest from @gungulati and team in collab with #MattFreedman. #LiquidBiopsy can reveal gene expression in cancer by integrating circulating histone mods and cfDNA fragmentation patterns. Excited to see how this expands the reach of precision oncology!
Gunsagar Gulati
@gungulati
Feb 20
We infer earthquakes from distant vibrations and stars from photons emitted light-years away. Can we reconstruct a patient’s tumor biology from the signals it sheds into blood? Introducing APEX (Associating Plasma Epigenomics with eXpression), our framework for inferring cancer expression from plasma. Preprint: biorxiv.org/content/10.64898… @biorxivpreprint @DanaFarber @DrChoueiri @SylvanBacaLab #FreedmanLab
7
28
4,798
RFA for SUO Fellows & YUO Members! Apply by March 1, 2026 for up to $25,000 to develop innovative, patient-centered clinical trial concepts in urologic oncology. Funding & mentorship from SUO leaders. Apply here: bit.ly/46NmtII
6
3
1,735
Navonil DS retweeted
Di Zhao MDA@Dr_Di_Zhao
Feb 2
Many thanks to @UroToday for highlighting our study published in @NatureCancer! ♥️Truly appreciate the 10-year unwavering supports from @PCFnews for launching my career in #Prostate Cancer research! 🌹
UroToday.com
@urotoday
Feb 2
Cholesterol synthesis fuels androgen growth in SPOP/CHD1-altered #Prostate tumors. @Dr_Di_Zhao @MDAndersonNews joins @AndreaMiyahira @PCFnews a @NatureCancer study examining CHD1 loss and SPOP mutations in #ProstateCancer. The team demonstrated that combining FDA-approved atorvastatin with abiraterone showed synergistic anti-tumor effects in preclinical models. #WatchNow to learn more > bit.ly/49j6pQW
2
8
1,206
Load more